Calidi Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLDI and other ETFs, options, and stocks.About CLDI
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
CEOEric E. Poma
CEOEric E. Poma
Employees28
Employees28
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees28
Employees28
CLDI Key Statistics
Market cap7.95M
Market cap7.95M
Price-Earnings ratio-0.13
Price-Earnings ratio-0.13
Dividend yield—
Dividend yield—
Average volume78.23K
Average volume78.23K
High today$1.12
High today$1.12
Low today$1.07
Low today$1.07
Open price$1.12
Open price$1.12
Volume16.42K
Volume16.42K
52 Week high$19.20
52 Week high$19.20
52 Week low$1.05
52 Week low$1.05
Stock Snapshot
Calidi Biotherapeutics(CLDI) stock is priced at $1.10, giving the company a market capitalization of 7.95M. It carries a P/E multiple of -0.13.
On 2026-01-14, Calidi Biotherapeutics(CLDI) stock moved within a range of $1.07 to $1.12. With shares now at $1.10, the stock is trading +2.4% above its intraday low and -1.8% below the session's peak.
Trading activity shows a volume of 16.42K, compared to an average daily volume of 78.23K.
The stock's 52-week range extends from a low of $1.05 to a high of $19.20.
The stock's 52-week range extends from a low of $1.05 to a high of $19.20.
People also own
Based on the portfolios of people who own CLDI. This list is generated using Robinhood data, and it’s not a recommendation.